Diabetes mellitus type 2 overview: Difference between revisions

Jump to navigation Jump to search
(New page: {{Diabetes mellitus type 2}} {{Diabetes mellitus}} '''For patient information click [[{{PAGENAME}} (patient information)|here]]'''. {{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamva...)
 
No edit summary
Line 5: Line 5:
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org]; {{CZ}}
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org]; {{CZ}}


==Overview==
'''Diabetes mellitus type 2''' (formerly called non [[insulin]]-dependent diabetes (NIDDM), obesity related diabetes, or adult-onset diabetes) is a [[metabolism|metabolic]] disorder that is primarily characterized by [[insulin resistance]], relative insulin deficiency, and [[hyperglycemia]]. It is often managed by engaging in exercise and modifying one's diet. It is rapidly increasing in the developed world, and there is some evidence that this pattern will be followed in much of the rest of the world in coming years. The [[Centers for Disease Control and Prevention|CDC]] has characterized the increase as an [[epidemic]].<ref>{{Citation
'''Diabetes mellitus type 2''' (formerly called non [[insulin]]-dependent diabetes (NIDDM), obesity related diabetes, or adult-onset diabetes) is a [[metabolism|metabolic]] disorder that is primarily characterized by [[insulin resistance]], relative insulin deficiency, and [[hyperglycemia]]. It is often managed by engaging in exercise and modifying one's diet. It is rapidly increasing in the developed world, and there is some evidence that this pattern will be followed in much of the rest of the world in coming years. The [[Centers for Disease Control and Prevention|CDC]] has characterized the increase as an [[epidemic]].<ref>{{Citation
   | last =Gerberding
   | last =Gerberding

Revision as of 00:26, 14 September 2011

Diabetes mellitus main page

Diabetes mellitus type 2 Microchapters

Home

Patient information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Diabetes Mellitus Type 2 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical therapy

Life Style Modification
Pharmacotherapy
Glycemic Control

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Diabetes mellitus Main page

Patient Information

Type 1
Type 2

Overview

Classification

Diabetes mellitus type 1
Diabetes mellitus type 2
Gestational diabetes

Differential Diagnosis

Complications

Screening

Diagnosis

Prevention

For patient information click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]

Overview

Diabetes mellitus type 2 (formerly called non insulin-dependent diabetes (NIDDM), obesity related diabetes, or adult-onset diabetes) is a metabolic disorder that is primarily characterized by insulin resistance, relative insulin deficiency, and hyperglycemia. It is often managed by engaging in exercise and modifying one's diet. It is rapidly increasing in the developed world, and there is some evidence that this pattern will be followed in much of the rest of the world in coming years. The CDC has characterized the increase as an epidemic.[1]

Unlike Type 1 diabetes, there is little tendency toward ketoacidosis in Type 2 diabetes, though it is not unknown. One effect that can occur is nonketonic hyperglycemia. Complex and multifactorial metabolic changes lead to damage and function impairment of many organs, most importantly the cardiovascular system in both types. This leads to substantially increased morbidity and mortality in both Type 1 and Type 2 patients, but the two have quite different origins and treatments despite the similarity in complications.

References

  1. Gerberding, Julie Louise (2007-05-24), Diabetes, Disabling Disease to Double by 2050, CDC

Template:WH Template:WS